Company News
05 Feb 2025
Lumos CEO Doug Ward and CFO Barrie Lambert present the Company's latest quarterly performance, highlighting strong revenue growth and key developments. The presentation covers recent achievements including BARDA funding for clinical trials, progress on major partnerships, and updates on product development initiatives, followed by a detailed Q&A session.
Take a look:
A few more pieces along the same thread. See the full index for everything.
COMPANY NEWS
1 min read
MST Access has published a research report on Lumos Diagnostics Limited.
COMPANY NEWS
2 min read
Lumos Diagnostics has announced further progress in the U.S. commercialisation of FebriDx® across its priority top-100 urgent care target list.
COMPANY NEWS
1 min read
Lumos CEO Doug Ward, Lumos Chief Commercial Officer Paul Kase, Lumos Director of U.S. Sales